Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF

VanEck's concentrated 26-stock portfolio delivered stronger five-year returns and lower volatility, while State Street's 62-holding fund offers broader diversification and lower fees.

We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.

Read the original at fool.com →

More in Health & Medicine

More from Friday 30 October →